Lead in bone can be measured in vivo using -y-rays from a l09Cd source to excite lead K X-rays. Normalization of lead X-ray amplitudes to that of the elastically backscattered 88 keV y-rays produces a determination of the concentration of lead in bone mineral that is accurate and insensitive to variations in measurement or bone geometry. For in vivo tibia measurements, a typical precision (1 SD) of ± 5 ,g lead (g bone mineral)-' is achieved for an effective dose equivalent of 2.1 tSv. Measurement can be made of any superficial bone site, but precision will vary approximately as the inverse of the square root of the mass of bone mineral sampled. The apparatus required for this technique is readily transportable, and mobile laboratory facilities are easily established.
Introduction
The noninvasive measurement of bone lead humans was first reported by Ahlgren et al. in 1976 (1) . Their X-ray fluorescence system used 'y-rays from 57Co to excite the K series X-rays of lead. This approach has been further developed (2, 3) and adopted elsewhere (4) . Sub- sequently, an alternative approach, which used '09Cd rather than 57Co to excite lead K-series X-rays, was proposed (5) and developed (6, 7) . A substantially different methodology, while still being X-ray fluorescence, has been employed in measuring bone lead by means ofthe L-series X-rays, using either radioisotope sources (8, 9) or polarized X-rays (10) as the incident radiation. It is the use of '09Cd to excite lead K-series X-rays that will be considered here, as this approach has considerable flexibility in being able to sample lead in a range of different bone sites and a robust normalization technique, which obviates the need to correct for bone geometry, thickness of overlying tissue, and other factors. 109Cd Technique for K X-Ray Fluorescence of Lead
The equipment used in these measurements is shown schematically in Figure 1 . '09Cd emits ay-rays of 88.035 keV, just above the 88.005 keV K-shell absorption edge in lead, in 3.6% of its decays; it also emits silver K X-rays of 22 or 25 keV with an intensity 25 to 30 times higher. These silver X-rays are filtered out by 0.5 mm of copper in front of the source, which has little effect on the intensity of 88 keV 'y-rays. The ay-rays can interact with a K-shell electron in lead, ejecting it with the resulting vacancy being filled by less tightly bound electrons and energy being released as K-series X-rays (96% of transitions) or Auger electrons.
In addition, Compton scattering of incident a-rays can occur in the subject, resulting in scattered photons of reduced energy, the energy depending on the angle of scatter. In this case (Fig. 1) , the mean angle of scatter is a little over 1500, and the corresponding energy of Compton-scattered photons is 66.5 keV. A large angle of scatter is an essential feature of the use of 109Cd to measure lead because the Compton-scatter peak is then well below the X-ray peaks; for example, were a 900 scattering angle used, this would result in Compton-scattered photons of 75.1 keV, which would obscure the lead Ka X-rays.
Elastic scattering, the remaining important process characterizing this technique, results in a scattered photon, essentially of unchanged energy; the photon direction is usually only slightly altered but occasionGe detectorLil 0 50mm FIGURE 1. Equipment for K X-ray fluorescence of lead using "'Cd. 
Elastic Scatter Normalization
As noted above, elastic scattering, particularly at these large angles (-1500), is a low probability event compared to Compton scattering. However, the crosssection at this energy and angle varies very strongly with the atomic number (z) ofa target atom. This variation is illustrated in Figure 3 over a range of elements found in human tissue. Since the cross-section depends on the fifth or sixth power ofz, the observed elastic scatter peak comes predominantly from the higher z elements present. In the case of a bone, such as tibia or calcaneus, 98 to 99% of the elastic scatter signal arises from the bone mineral, rather than other tissue components. Two further factors are also pertinent to the normalization process. First, the lead X-ray signal also arises from the bone as this is the principal storage site for lead and no subsidiary storage site, such as liver or kidney, is likely to be in view during a bone lead measurement. Also, although lead concentration in bone has been shown to vary sharply over distances of the order of 100 itm (11) , it is effectively uniformly distributed on the integrated scale defined by the penetration of lead K X-rays (-30 mm). Second, effectively, only uncollided incident ay-rays can produce lead K X-rays because the 88.035 keV y-rays from '09Cd are only some 30 eV above the lead K absorption edge. Thus it is the same photon fluence that gives rise to both the elastic scatter peak and the lead K X-ray peaks. The combination of these three factors produces a robust normalization of lead to bone mineral when the ratio is taken of the amplitudes of lead K X-rays to the elastic scatter peak. The effectiveness of this normalization procedure is shown by Figure 4 Figure 1. how the ratio of lead X-ray to elastic amplitude is insensitive to either source to sample distance or thickness of overlying tissue, despite marked variations in lead X-ray counts alone.
The X-ray to elastic ratio observed in bones is calibrated against plaster of Paris (calcium sulfate) phantoms doped with known quantities of lead. A correction then has to be made to allow for the difference in elastic scattering cross-section between plaster of Paris and bone mineral. The cross-sections have been interpolated from the tabulated data of Hubbell and Overbo (12) . As can be seen from Table 1 , the cross-sections are a weakly varying function of angle, so the fact that a range of angles is subtended in any measurement system is unlikely to distort the normalization; thus, the mean scattering angle in a particular measurement geometry can be used.
Quantitation, Precision, and Dose
Although the lead Ka, and Ka2 X-rays are the most intense, the background underlying the Kf31 and K,3 is so much less that they can still contribute usefully to the overall precision. However, in order to extract data from the Kfl,,3 peaks, account must be taken of the feature at 84.0 keV, which is an edge marking the upper end of the bremsstrahlung spectrum of photoelectrons ejected from the K shell of calcium by the 88 keV -y-rays (13) . There are less prominent, but analogous features, at 85.9 keV from phosphorus, in the case ofbone mineral, and at 85.6 keV from sulfur, in the case of plaster of Paris. The lead Kj32 line, although used for in vitro analyses, is not used for in vivo analyses because there is an oxygen photoelectron bremsstrahlung edge that interferes with it. The height of this latter feature varies with the amount of soft tissue overlying and surrounding the bone.
The measurement precision, although not the accuracy, varies somewhat from person to person, depending on factors such as the amount of overlying tissue and the mass ofbone mineral sampled. In a typical field survey of in vivo tibia lead measurements, the standard deviation on an individual measurement (gi) varies from about ± 3.5 to ± 10.0 itg lead (g bone mineral)-' for a skin dose of 0.5 mGy. The corresponding root mean square standard deviation, that is, The effective (whole body) dose equivalent of 2.1 ySv is low and can be put in context by comparison to natural background radiation. Such exposures vary from place to place but are often in the range of 2 to 3 mSv per year. Thus, the dose delivered during a bone lead measurement is approximately equivalent to 6 to 9 hr of natural background radiation.
Comparisons between X-Ray Fluorescence and Atomic Absorption Spectroscopy
In order to validate the '09Cd K X-ray fluorescence technique for bone lead measurements, sets of bone samples have been analyzed both by atomic absorption spectroscopy and by X-ray fluorescence. Atomic absorption spectroscopy measurements were performed by Wittmers et al. in the manner they have described previously (14) . The samples used were about 20 mg of bone mineral and were removed prior to the samples being analyzed by X-ray fluorescence. The X-ray fluorescence technique sampled up to 10 to 15 g of bone mineral, less in the case of tibia fragments. Thus, the masses of the bones sampled by the two techniques were significantly different. The data comparing the two measurement techniques have been reported previously (15, 16) and are summarized in Table 3. Table 3 shows the mean differences between X-ray fluorescence and atomic absorption measurements, their standard deviation, and the reduced x2 statistics, as a test of observed variance ofthe differences compared to their pooled measurement variances. There is clearly no evidence for a systematic difference in the results obtained by the two different techniques, and it is unlikely that a difference ofmore than 3 jg lead (g bone mineral)-' could exist. The x2 is highly significant, indicating that there is greater random variation between the measurements than that predicted by the known measurement precisions of the two techniques. It is probable that at least some ofthis increased variance is associated with the different masses of bones sampled.
Sampling Different Bone Sites
The '09Cd K X-ray fluorescence technique has been used to sample different bone sites, principally tibia and calcaneus, although other bones have been measured in individuals and on surveys. The initial reason for measuring more than one bone site was to sample differing types of bone, the midshaft of the tibia being largely cortical, while the calcaneus is trabecular apart from a thin cortical sheath. Rather surprisingly, the correlation between calcaneus and tibia in a crosssectional survey, which included retired as well as active lead workers, was very strong (r = 0.893, n = 112) (17) . This relationship is illustrated in Figure 5 .
One important factor in deciding on which bone sites to sample is the precision that will be obtained on the measurements. Precision depends on the mass of bone mineral sampled, the amount of tissue overlying the bone, and the geometry of the measurement. The resulting wide differences in the height of the elastic scatter peak are illustrated by Figure 6 , which shows these portions of spectra from measurements at four different bone sites on the same person. The precision, which varies inversely with the square root of the area of the elastic scatter peak, ranged from ± 4.1 itg lead (g bone mineral)-' for a tibia measurement to ± 23.2 Fg lead (g bone mineral)-' for a rib measurement.
A second important factor in choosing a bone site is the degree to which it might be representative of the entire bone mass in the body. Wittmers et al. (18) studies of childhood lead exposure. In appropriate circumstances, there is every reason to expect it to yield valuable and quantitatively reliable information, but the precision obtained in measuring a child's tibia will be worse than that for an adult because the mass of bone mineral sampled will be considerably less. Also, interpretation of such data would be more complex than for adult studies, as a smaller and more variable proportion of a child's lead body burden is found in bone (20) . Finally, it should be noted that these bone lead measurements can be conducted from a mobile facility, making it relatively convenient to conduct field surveys.
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